Proactive specialist asset management

We provide venture, private equity or debt finance to regional businesses with growth ambition.

Read more

Championing regional businesses

Providing the best possible support to our portfolio businesses and partners.

Read more

We are #onemercia

Striving to be the first choice for our investors, investees and colleagues.

Read more

Watch, read, listen, share.

The dedicated home of Mercia’s exclusive portfolio interviews, deep-dive blogs, insightful podcasts and educational webinars; all delivered by business leaders and industry experts.

Read more

Your ideal investment partner

Discover more about our Group including our approach to corporate governance and driving shareholder value

Read more

News

Search all news stories

  • Clear filters

Direct Investments

Investment in nDreams

20th January, 2015

Mercia EIS Funds

Mercia’s £70m flotation wins deal of the month

20th January, 2015

Direct Investments

Martin Lamb appointed as a non-executive director

14th January, 2015

Mercia EIS Funds

Startup competition launches

14th January, 2015

Direct Investments

Admission to AIM with £106m market capitalisation – £70m raised

12th December, 2014

Direct Investments

Virtual Reality set to deliver a ‘seismic change’ within the gaming industry

19th November, 2014

Mercia EIS Funds

Investing in gaming start-ups

13th November, 2014

Mercia EIS Funds

Edge Case Games investment

8th October, 2014

Mercia EIS Funds

Soccer Manager

26th September, 2014

Mercia EIS Funds

Aston Eyetech investment

25th September, 2014

Mercia EIS Funds

Mercia makes automotive sector investment in Impressions Technologies Ltd

18th September, 2014

Mercia EIS Funds

Mercia makes £229,000 investment in Inocardia

18th September, 2014

Mercia EIS Funds

Tutortap wins Mercia’s Investment Pitch

27th August, 2014

Mercia EIS Funds

Abzena IPO

24th August, 2014

Mercia EIS Funds

Mercia Digital Fund launch

15th August, 2014

Mercia EIS Funds

Oxford Genetics secures additional funding from Mercia and TSB

30th July, 2014

Mercia EIS Funds

Mercia Fund Management makes £229,000 investment in InoCardia

21st July, 2014

Mercia EIS Funds

Finance Bill should boost Britain’s world-leading technology firms

17th July, 2014

Mercia EIS Funds

Abzena float represents a profitable return for Mercia’s investors

11th July, 2014

Mercia EIS Funds

Abzena raises £20 million in connection with forthcoming admission to AIM

9th July, 2014

Mercia EIS Funds

Abzena intention to float

18th June, 2014

Mercia EIS Funds

Mercia Fund Management makes £150,000 investment in Dab Gaming

10th June, 2014

Mercia EIS Funds

Antitope and Baylor Institute for Immunology Research to Collaborate to Produce Manufacturing Cell Line for Novel Therapeutic Dendritic-cell-targeting Vaccine

6th June, 2014

Mercia EIS Funds

Mercia Fund Management launches start-up competition

4th June, 2014

Mercia EIS Funds

PsiOxus Therapeutics announces positive study results of oncolytic vaccine enadenotucirev at 2014 ASCO Annual Meeting

3rd June, 2014

Mercia EIS Funds

PolyTherics and Antitope form Abzena

27th May, 2014

Mercia EIS Funds

BioExtractions Wales completes funding round for innovative extraction service

19th May, 2014

Mercia EIS Funds

Mercia Fund Management launches flexible, cost effective workspace for early stage gaming and technology businesses

14th May, 2014

Mercia EIS Funds

Mercia Fund Management agrees second stage funding for VirtTrade

12th May, 2014

Mercia EIS Funds

Mercia Fund Management backs social media duo Crowd Reactive and TorqBak

8th May, 2014

Mercia EIS Funds

Thalia Design Automation Ltd completes A round funding and prepares to launch suite of Analog and Power design optimisation tools

29th April, 2014

Mercia EIS Funds

Mercia Fund Management boosts portfolio with Canary investment

25th April, 2014

Mercia EIS Funds

Mercia mention in FT.com “Getting exposure to UK tech”

23rd April, 2014

Mercia EIS Funds

PolyTherics and MacroGenics extend Collaboration to Produce Novel Antibody Drug Conjugates

11th April, 2014

Mercia EIS Funds

Mercia Fund Management makes gaming sector investments in nDreams and No Yetis Allowed

7th April, 2014

Mercia EIS Funds

Concurrent Thinking secures £400,000 funding boost

2nd April, 2014

Mercia EIS Funds

Mercia Fund Management boosts digital portfolio with DMPortal investment

28th March, 2014

Mercia EIS Funds

Budget 2014 – SEIS is now permanent as tax breaks for investment in SMEs continue

19th March, 2014

Mercia EIS Funds

Budget: keep tax incentives to encourage investment in SMEs urges VC fund manager

17th March, 2014

Mercia EIS Funds

Mercia mention in FT Adviser Guide to Enterprise Investment Schemes (EIS)

13th March, 2014

Mercia EIS Funds

IFA Magazine – Time is geting tight to invest in EIS for this tax year

12th March, 2014

Mercia EIS Funds

Mercia Fund Management ups its game with former Codemasters CEO appointment

28th February, 2014

Mercia EIS Funds

Smart Antenna Technologies secures extra funding

19th February, 2014

Mercia EIS Funds

IFA Magazine – EIS investment is on the rise, but where is the capital being allocated?

7th February, 2014

Mercia EIS Funds

IFA Magazine – High Returns Don’t Always Mean High Risk

3rd February, 2014

Mercia EIS Funds

MFM featured in Growth Business on the need to increase the SEIS threshold

31st January, 2014

Mercia EIS Funds

Mercia Growth Fund 3 announced – the latest hybrid EIS/SEIS investment fund from Mercia Fund Management

19th December, 2013

Mercia EIS Funds

MFM mentioned in FT on why crowdfunding isn’t right for many start-ups

18th December, 2013

Mercia EIS Funds

Simon Cartmell, healthcare expert and ex CEO of ApaTech, joins Mercia Fund Management Investment Panel

4th December, 2013

Mercia EIS Funds

Autumn statement 2013: raise the seed funding cap or SMEs won’t flourish

29th November, 2013

Mercia EIS Funds

Warwick Audio secures £1.25 million investment package

27th November, 2013

Mercia EIS Funds

Kwanji successfully closes initial seed funding round led by MFM

26th November, 2013

Mercia EIS Funds

Mid-Stage Clinical Study of Wasting Disease Therapeutic MT-102 Shows Reversal of Cancer-Related Wasting

12th November, 2013

Mercia EIS Funds

Mercia Fund Management holds Open House for companies seeking investment

30th October, 2013

Mercia EIS Funds

Drug discovery services company CYP Design Ltd completes seed funding round

25th October, 2013

Mercia EIS Funds

Mercia Fund Management appoints Sales and Investor Relations Manager – Talon Golding

23rd October, 2013

Mercia EIS Funds

PsiOxus Therapeutics named EuropaBio’s Most Innovative European Biotech SME

3rd October, 2013

Mercia EIS Funds

World First: The Native Antigen Company succeeds in manufacturing all four DENV NS1 serotypes from human cell lines

1st October, 2013

Mercia EIS Funds

Mercia Fund Management makes first digital sector investment with Metric

30th September, 2013

Mercia EIS Funds

Mercia Fund Management announces Mike Hayes as head of new digital division

18th September, 2013

Mercia EIS Funds

Smart Antenna Technologies brings single antenna solution to cellular handsets

21st August, 2013

Mercia EIS Funds

Antitope Announces Research Agreement with ChemomAb for Generation of Composite Human Antibodies against Inflammatory Diseases

31st July, 2013

Mercia EIS Funds

Mercia Fund Management makes investment to help accelerate the growth of PolyTherics

29th July, 2013

Mercia EIS Funds

Oxford Genetics secures funding for DNA cloning system

24th July, 2013

Mercia EIS Funds

How Mercia Fund Management funds University of Keele spin-outs

26th June, 2013

Mercia EIS Funds

PsiOxus Therapeutics initiates second clinical study of oncolytic vaccine

24th June, 2013

Mercia EIS Funds

Ventive named national runner up in Shell Springboard awards 2013

18th June, 2013

Mercia EIS Funds

Irresistible Materials secures funding boost and new Chairman

23rd May, 2013

Mercia EIS Funds

Shell Springboard regional winner Ventive secures £900,000 funding

9th May, 2013

Mercia EIS Funds

Dr Christine Wilkinson Blanc joins Psioxus Therapeutics as Chief Medical Officer

8th May, 2013

Mercia EIS Funds

Mercia Fund Management announces Carlton Jones as nanoTherics’ CEO

15th April, 2013

Mercia EIS Funds

Mercia Fund Management announces first SEIS investments from the Mercia Growth Fund 1

9th April, 2013

Mercia EIS Funds

Oxford’s Native Antigen Company receives funding boost

4th April, 2013

Mercia EIS Funds

Mercia Fund Management announces its first EIS investments from Mercia Growth Fund 1

27th March, 2013

Mercia EIS Funds

Why SEIS is particularly attractive for 2013/14

25th March, 2013

Mercia EIS Funds

Mercia Fund Management holds first Open House for SEIS and EIS investees

15th March, 2013

Mercia EIS Funds

PolyTherics receives milestone payment as Celtic Pharma progresses development of long-acting version of Blood Factor VIII produced using PolyTherics’ TheraPEG™ technology

8th March, 2013

Mercia EIS Funds

Mercia Fund Management launches Mercia Growth Fund 2 – a new hybrid EIS/SEIS investment opportunity

6th March, 2013

Mercia EIS Funds

PsiOxus Therapeutics completes patient enrolment for Phase II wasting disease therapeutic MT-102

4th March, 2013

Mercia EIS Funds

Forward Group takes equity stake in Mercia Fund Management

18th February, 2013

Mercia EIS Funds

DTRA awards US$3.3m contract to psioxus therapeutics to develop biodefence vaccine adjuvants

17th January, 2013

Mercia EIS Funds

Mercia Fund Management announces over subscription to the SEIS portion of Mercia Growth Fund 1

21st November, 2012

Mercia EIS Funds

Allinea MAPs Out New Performance Tool

13th November, 2012

Mercia EIS Funds

National newspapers cover Mercia SEIS Fund

7th November, 2012

Mercia EIS Funds

Mercia Fund Management highlights combined SEIS and EIS Funds at VCT and EIS Investor Forum

6th November, 2012

Mercia EIS Funds

UK Government Awards 1.7M Grant To Psioxus Therapeutics For Second Phase I/II Clinical Trial Of Cancer Vaccine

31st October, 2012

Mercia EIS Funds

Biotecnol and PolyTherics enter into a Research Collaboration for the Development of Tribody Antibody Drug Conjugates

28th October, 2012

Mercia EIS Funds

Talking about the West Midlands European Regional Development Fund Programme

18th October, 2012

Mercia EIS Funds

PolyTherics expands collaboration with a top five pharmaceutical company to enhance the clinical properties of biopharmaceuticals using PolyPEG

16th October, 2012

Mercia EIS Funds

Talking university spin-outs – University of Warwick

1st October, 2012

Mercia EIS Funds

Psioxus Launches Phase I/II Clinical Trial Of Oncolytic Vaccine With Dosing Of Patient With Metastatic Colorectal Cancer

26th September, 2012

Mercia EIS Funds

Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust

13th September, 2012

Mercia EIS Funds

Mercia Fund Management congratulates PsiOxus Therapeutics on Best Biotech Fund Raiser award

12th September, 2012

Mercia EIS Funds

Pro Bono Bio obtains exclusive licence from PolyTherics

10th September, 2012

Mercia EIS Funds

Looking at university spin-outs: University of Birmingham

6th September, 2012

Mercia EIS Funds

PolyTherics appoints new head of business development

21st August, 2012

Mercia EIS Funds

Hybrid SEIS scheme investment fund launched – the Mercia Growth Fund

20th July, 2012

Mercia EIS Funds

PolyTherics granted further patents for TheraPEG and GlycoPol

18th June, 2012

Mercia EIS Funds

Allinea DDT the debugger of choice for the worlds most powerful supercomputer.

17th June, 2012
Loading...